FdaApplication
NDA 208969
Identifiers
- fda_app_no: NDA208969
Properties
| Property | Value |
|---|---|
| applicant_name | AMPHASTAR PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2023-03-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REXTOVY | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED;NASAL |
1 product